|
DUBLIN, Feb. 14, 2024 /PRNewswire/ -- The "Olanzapine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.
The global olanzapine market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 2.1% from 2024 to 2030.
The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets. The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain.
With these strategies olanzapine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.
Olanzapine Market Insights
- Oral segment will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.
- North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.
Key Topics Covered:
1. Executive Summary
2. Global Olanzapine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Olanzapine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Olanzapine Market by Route of Administration
3.3.1: Oral
3.3.2: Parenteral
3.4: Global Olanzapine Market by Application
3.4.1: Bipolar disorder
3.4.2: Schizophrenia
3.4.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Olanzapine Market by Region
4.2: North American Olanzapine Market
4.2.2: North American Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
4.3: European Olanzapine Market
4.3.1: European Olanzapine Market by Route of Administration: Oral and Parenteral
4.3.2: European Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
4.4: APAC Olanzapine Market
4.4.1: APAC Olanzapine Market by Route of Administration: Oral and Parenteral
4.4.2: APAC Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
4.5: ROW Olanzapine Market
4.5.1: ROW Olanzapine Market by Route of Administration: Oral and Parenteral
4.5.2: ROW Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Olanzapine Market by Route of Administration
6.1.2: Growth Opportunities for the Global Olanzapine Market by Application
6.1.3: Growth Opportunities for the Global Olanzapine Market by Region
6.2: Emerging Trends in the Global Olanzapine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Olanzapine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Olanzapine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Dr Reddy's laboratory
7.2: Watson pharmaceuticals
7.3: Lilly
7.4: Hamson pharmaceuticals
7.5: Sun pharmaceuticals
7.6: Sandoz pharmaceuticals
7.7: Torrent pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/r/tebap2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
 View original content:https://www.prnewswire.com/news-releases/global-olanzapine-markets-2018-2023-and-2024-2030---rise-in-the-prevalence-of-neurological-conditions-spurring-growth-302062177.html
SOURCE Research and Markets
|
